Danaher Corporation (NYSE:DHR) Receives Consensus Rating of “Moderate Buy” from Brokerages

Shares of Danaher Corporation (NYSE:DHR) have been assigned an average recommendation of “Moderate Buy” from the twenty-five analysts that are presently covering the firm, Marketbeat.com reports. Five analysts have rated the stock with a hold rating, nineteen have assigned a buy rating and one has given a strong buy rating to the company. The average 12 month price target among brokers that have updated their coverage on the stock in the last year is $228.9130.

DHR has been the subject of several recent analyst reports. DZ Bank started coverage on shares of Danaher in a research report on Wednesday, June 3rd. They set a “buy” rating and a $210.00 price objective for the company. Guggenheim dropped their target price on shares of Danaher from $235.00 to $200.00 and set a “buy” rating on the stock in a report on Wednesday, July 22nd. HSBC decreased their price target on Danaher from $270.00 to $230.00 and set a “buy” rating for the company in a report on Wednesday, June 3rd. Evercore reissued an “outperform” rating and issued a $230.00 price objective on shares of Danaher in a research report on Monday, July 6th. Finally, Wolfe Research downgraded Danaher from an “outperform” rating to a “peer perform” rating in a research note on Monday, June 1st.

Danaher Price Performance

Danaher stock opened at $215.78 on Friday. The stock’s 50 day moving average is $197.17 and its 200 day moving average is $192.36. Danaher has a one year low of $160.93 and a one year high of $242.80. The firm has a market cap of $151.69 billion, a P/E ratio of 38.33, a P/E/G ratio of 2.68 and a beta of 0.78. The company has a debt-to-equity ratio of 0.48, a current ratio of 1.65 and a quick ratio of 1.25.

Danaher (NYSE:DHR) last released its earnings results on Monday, July 20th. The conglomerate reported $1.94 earnings per share for the quarter, beating analysts’ consensus estimates of $1.85 by $0.09. The business had revenue of $6.26 billion during the quarter, compared to the consensus estimate of $6.12 billion. Danaher had a net margin of 15.95% and a return on equity of 11.04%. The company’s revenue for the quarter was up 5.5% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.77 EPS. As a group, research analysts expect that Danaher will post 8.53 EPS for the current year.

Hedge Funds Weigh In On Danaher

Institutional investors and hedge funds have recently modified their holdings of the business. California State Teachers Retirement System lifted its position in shares of Danaher by 18,856.0% during the 2nd quarter. California State Teachers Retirement System now owns 184,571,691 shares of the conglomerate’s stock valued at $35,157,216,000 after acquiring an additional 183,598,005 shares during the period. BlackRock Inc. acquired a new stake in Danaher in the second quarter worth $10,492,520,000. State Street Corp increased its stake in Danaher by 1.7% in the fourth quarter. State Street Corp now owns 27,681,334 shares of the conglomerate’s stock valued at $6,345,529,000 after purchasing an additional 472,608 shares in the last quarter. Capital International Investors raised its holdings in shares of Danaher by 8.9% during the fourth quarter. Capital International Investors now owns 18,246,008 shares of the conglomerate’s stock valued at $4,177,386,000 after purchasing an additional 1,487,768 shares during the period. Finally, Wellington Management Group LLP raised its holdings in shares of Danaher by 10.4% during the second quarter. Wellington Management Group LLP now owns 16,316,834 shares of the conglomerate’s stock valued at $3,108,031,000 after purchasing an additional 1,542,310 shares during the period. 79.05% of the stock is currently owned by institutional investors.

About Danaher

Danaher Corporation (NYSE: DHR) is a global science and technology company that designs, manufactures and markets products and services for the life sciences, diagnostics, and environmental and applied markets. The company organizes its operations into business segments focused on Life Sciences, Diagnostics, and Environmental & Applied Solutions, supplying instruments, reagents, software and related services that support research, clinical testing, biopharmaceutical development, and industrial and environmental monitoring.

Products and services in Danaher’s portfolio include analytical and diagnostic instruments, laboratory consumables and reagents, digital and software solutions for workflow and data management, field and industrial monitoring equipment, and service and maintenance programs.